Xu Yuejuan
Place
-
Now28th
-
Last week25th
-
Two weeks ago26th
-
Three weeks ago26th
- Name
- Xu Yuejuan
- Net Worth
- 1.1 Billion USD
- Birth Date
- 24 January 1962
- Age
- 63
- Country
- China
- City
- Hangzhou
- Business
- Manufacturing
Xu Yuejuan is a prominent billionaire from China, recognized for her entrepreneurial success in the pharmaceutical and healthcare industries. Born and educated in China, Xu embarked on her entrepreneurial journey with a focus on healthcare innovation and medical technology.
Xu Yuejuan's breakthrough came with her leadership in founding and expanding Hansoh Pharmaceutical Group Co., Ltd., a leading biopharmaceutical company in China. Under her stewardship, Hansoh Pharmaceutical has become renowned for its research, development, and manufacturing of innovative drugs across therapeutic areas such as oncology, psychiatry, and cardiovascular diseases. The company's commitment to quality and innovation has propelled it to the forefront of China's pharmaceutical industry.
Beyond pharmaceuticals, Xu has diversified Hansoh Pharmaceutical's portfolio into healthcare services, medical devices, and biotechnology sectors. Her strategic investments and partnerships have further solidified the company's position as a key player in China's healthcare landscape.
Xu Yuejuan is also known for her philanthropic efforts, focusing on initiatives that support healthcare access, medical research, and education in China. She has established charitable foundations and contributed to various social welfare programs aimed at improving healthcare infrastructure and supporting disadvantaged communities.
As one of China's wealthiest individuals, Xu Yuejuan continues to drive innovation and economic growth through her entrepreneurial ventures and commitment to social responsibility. Her leadership in the pharmaceutical industry and dedication to advancing healthcare solutions underscore her role as a transformative figure in China's healthcare sector and global biopharmaceutical innovation.
Share
Your involvement